Company

PREFER: patient preferences

Research Services 3 employees

Employees: 3
Contacts: 1
Emails: 1

imi-prefer.eu LinkedIn

PREFER: patient preferences Overview

Website: imi-prefer.eu
Industry: Research Services
Employees: 3
Founded: 2016
NAICS: Scientific Research and Development Services

Research and Development in the Physical, Engineering, and Life Sciences

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Keywords

patient preferences medical product development patient engagement

About PREFER: patient preferences

The Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (PREFER) project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115966. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA. PREFER looks at how and when it is best to perform and include patient preferences in decision making during the medical product life cycle. We include patient stakeholders at every level of the project. The end-result will be recommendations to support development of guidelines for industry, Regulatory Authorities, and HTA bodies.

PREFER: patient preferences Contact Details

People in AeroLeads: 3
With contact data: 1
Email contacts: 1; 33.3% coverage

PREFER: patient preferences Org Chart

Sample employees and titles

Name	Title	Location	Contact
Liam Findley			View
Josepine Fernow		Greater Uppsala Metropolitan Area, Sweden	Email
Anna Holm Bodin	Forskningskommunikatör - Communicating	Uppsala, Uppsala County, Sweden	View